Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Dec 31;3(6):871-873.
doi: 10.1016/j.jacbts.2018.10.001. eCollection 2018 Dec.

The Tafamidis Drug Development Program: A Translational Triumph

Mathew S Maurer  1 , Douglas L Mann  2
Affiliations
Editorial

The Tafamidis Drug Development Program: A Translational Triumph

Mathew S Maurer et al. JACC Basic Transl Sci. .
No abstract available

PubMed Disclaimer

References

    1. Maurer M.S., Schwartz J.H., Gundapaneni B. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med. 2018;379:1007–1016. - PubMed
    1. Sutton RI. Learning from success and failure. Harvard Business Review. June 2007. Available at: https://hbr.org/2007/06/learning-from-success-and-fail. Accessed December 3, 2018.
    1. Hammarstrom P., Schneider F., Kelly J.W. Trans-suppression of misfolding in an amyloid disease. Science. 2001;293:2459–2462. - PubMed
    1. Coelho T., Maia L.F., Martins da Silva A. Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial. Neurology. 2012;79:785–792. - PMC - PubMed
    1. Finkelstein D.M., Schoenfeld D.A. Combining mortality and longitudinal measures in clinical trials. Stat Med. 1999;18:1341–1354. - PubMed

Publication types